Using GEPIA database, we found that the expression of TRPM2 in tumor was higher than that of normal tissues (Fig. 5A) and predicted a poor prognosis of lung adenocarcinoma patients (Fig. 5B). This evidence concerns the gene TRPM2 and lung adenocarcinoma.